118 related articles for article (PubMed ID: 33936200)
21. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
22. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
Gao J; Meng Q; Zhao Y; Chen X; Cai L
BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia induced high expression of thioredoxin interacting protein (TXNIP) in non-small cell lung cancer and its prognostic effect.
Li Y; Miao LY; Xiao YL; Huang M; Yu M; Meng K; Cai HR
Asian Pac J Cancer Prev; 2015; 16(7):2953-8. PubMed ID: 25854388
[TBL] [Abstract][Full Text] [Related]
25. Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer.
Yang N; Liang Y; Yang P; Ji F
Oncol Rep; 2017 May; 37(5):2611-2619. PubMed ID: 28426124
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
27. A 17 gene panel for non-small-cell lung cancer prognosis identified through integrative epigenomic-transcriptomic analyses of hypoxia-induced epithelial-mesenchymal transition.
Chen YL; Zhang Y; Wang J; Chen N; Fang W; Zhong J; Liu Y; Qin R; Yu X; Sun Z; Gao F
Mol Oncol; 2019 Jul; 13(7):1490-1502. PubMed ID: 30973670
[TBL] [Abstract][Full Text] [Related]
28. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
29. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW
Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia‑induced galectin‑3 enhances RhoA function to activate the motility of tumor cells in non‑small cell lung cancer.
Kataoka Y; Ohshio Y; Teramoto K; Igarashi T; Asai T; Hanaoka J
Oncol Rep; 2019 Feb; 41(2):853-862. PubMed ID: 30535445
[TBL] [Abstract][Full Text] [Related]
31. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia exposure induced cisplatin resistance partially via activating p53 and hypoxia inducible factor-1α in non-small cell lung cancer A549 cells.
Guo Q; Lan F; Yan X; Xiao Z; Wu Y; Zhang Q
Oncol Lett; 2018 Jul; 16(1):801-808. PubMed ID: 29971135
[TBL] [Abstract][Full Text] [Related]
33. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
[TBL] [Abstract][Full Text] [Related]
34. Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.
Klein C; Dokic I; Mairani A; Mein S; Brons S; Häring P; Haberer T; Jäkel O; Zimmermann A; Zenke F; Blaukat A; Debus J; Abdollahi A
Radiat Oncol; 2017 Dec; 12(1):208. PubMed ID: 29287602
[TBL] [Abstract][Full Text] [Related]
35. Expression of microRNA-21 in non-small cell lung cancer tissue increases with disease progression and is likely caused by growth conditional changes during malignant transformation.
Haigl B; Vanas V; Setinek U; Hegedus B; Gsur A; Sutterlüty-Fall H
Int J Oncol; 2014 Apr; 44(4):1325-34. PubMed ID: 24452750
[TBL] [Abstract][Full Text] [Related]
36. Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients.
Ilie M; Hofman V; Zangari J; Chiche J; Mouroux J; Mazure NM; Pouysségur J; Brest P; Hofman P
Lung Cancer; 2013 Oct; 82(1):16-23. PubMed ID: 23910904
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells.
Zhang Y; He RQ; Dang YW; Zhang XL; Wang X; Huang SN; Huang WT; Jiang MT; Gan XN; Xie Y; Li P; Luo DZ; Chen G; Gan TQ
Cancer Cell Int; 2016; 16():89. PubMed ID: 27980454
[TBL] [Abstract][Full Text] [Related]
38. Effects of miR-221 on the apoptosis of non-small cell lung cancer cells by lncRNA HOTAIR.
Sun YJ; Li J; Chen CH
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4226-4233. PubMed ID: 31173294
[TBL] [Abstract][Full Text] [Related]
39. Expression profile of miRNA in NSCLC tissues in middle-altitude area.
Gu Y; Shi X; Wang X; Liu X; Xie Y
Oncol Lett; 2020 Jan; 19(1):783-794. PubMed ID: 31897195
[TBL] [Abstract][Full Text] [Related]
40. Regulation of angiogenic factors by the PI3K/Akt pathway in A549 lung cancer cells under hypoxic conditions.
Xie Y; Qi Y; Zhang Y; Chen J; Wu T; Gu Y
Oncol Lett; 2017 May; 13(5):2909-2914. PubMed ID: 28521397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
